Report Detail

Other Global Cell and Gene Therapy Manufacturing QC Market Size, Status and Forecast 2021-2027

  • RnM4312867
  • |
  • 20 April, 2021
  • |
  • Global
  • |
  • 121 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Safety Testing
    • 1.2.3 Purity Testing
    • 1.2.4 Potency Testing
    • 1.2.5 Identity Testing
    • 1.2.6 Stability Testing
  • 1.3 Market by Application
    • 1.3.1 Global Cell and Gene Therapy Manufacturing QC Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Precision Therapy
    • 1.3.3 Biological Research
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Cell and Gene Therapy Manufacturing QC Market Perspective (2016-2027)
  • 2.2 Cell and Gene Therapy Manufacturing QC Growth Trends by Regions
    • 2.2.1 Cell and Gene Therapy Manufacturing QC Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Cell and Gene Therapy Manufacturing QC Historic Market Share by Regions (2016-2021)
    • 2.2.3 Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Regions (2022-2027)
  • 2.3 Cell and Gene Therapy Manufacturing QC Industry Dynamic
    • 2.3.1 Cell and Gene Therapy Manufacturing QC Market Trends
    • 2.3.2 Cell and Gene Therapy Manufacturing QC Market Drivers
    • 2.3.3 Cell and Gene Therapy Manufacturing QC Market Challenges
    • 2.3.4 Cell and Gene Therapy Manufacturing QC Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue
    • 3.1.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue (2016-2021)
    • 3.1.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2016-2021)
  • 3.2 Global Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing QC Revenue
  • 3.4 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio
    • 3.4.1 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing QC Revenue in 2020
  • 3.5 Cell and Gene Therapy Manufacturing QC Key Players Head office and Area Served
  • 3.6 Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
  • 3.7 Date of Enter into Cell and Gene Therapy Manufacturing QC Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cell and Gene Therapy Manufacturing QC Breakdown Data by Type

  • 4.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Type (2016-2021)
  • 4.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2022-2027)

5 Cell and Gene Therapy Manufacturing QC Breakdown Data by Application

  • 5.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Application (2016-2021)
  • 5.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
  • 6.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Type
    • 6.2.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
    • 6.2.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
    • 6.2.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
  • 6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Application
    • 6.3.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
    • 6.3.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
    • 6.3.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
  • 6.4 North America Cell and Gene Therapy Manufacturing QC Market Size by Country
    • 6.4.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
    • 6.4.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
  • 7.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type
    • 7.2.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
    • 7.2.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
    • 7.2.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
  • 7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application
    • 7.3.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
    • 7.3.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
    • 7.3.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
  • 7.4 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country
    • 7.4.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
    • 7.4.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
  • 8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type
    • 8.2.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application
    • 8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region
    • 8.4.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
  • 9.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type
    • 9.2.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
    • 9.2.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
    • 9.2.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
  • 9.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application
    • 9.3.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
    • 9.3.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
    • 9.3.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
  • 9.4 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country
    • 9.4.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
    • 9.4.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
  • 10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type
    • 10.2.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application
    • 10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country
    • 10.4.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Bio-Techne Corporation
    • 11.1.1 Bio-Techne Corporation Company Details
    • 11.1.2 Bio-Techne Corporation Business Overview
    • 11.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Introduction
    • 11.1.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.1.5 Bio-Techne Corporation Recent Development
  • 11.2 BioMerieux SA
    • 11.2.1 BioMerieux SA Company Details
    • 11.2.2 BioMerieux SA Business Overview
    • 11.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Introduction
    • 11.2.4 BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.2.5 BioMerieux SA Recent Development
  • 11.3 Catalent, Inc.
    • 11.3.1 Catalent, Inc. Company Details
    • 11.3.2 Catalent, Inc. Business Overview
    • 11.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Introduction
    • 11.3.4 Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.3.5 Catalent, Inc. Recent Development
  • 11.4 Charles River Laboratories International Inc.
    • 11.4.1 Charles River Laboratories International Inc. Company Details
    • 11.4.2 Charles River Laboratories International Inc. Business Overview
    • 11.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Introduction
    • 11.4.4 Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.4.5 Charles River Laboratories International Inc. Recent Development
  • 11.5 Eurofins Scientific SE
    • 11.5.1 Eurofins Scientific SE Company Details
    • 11.5.2 Eurofins Scientific SE Business Overview
    • 11.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Introduction
    • 11.5.4 Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.5.5 Eurofins Scientific SE Recent Development
  • 11.6 F. Hoffmann-La Roche Ltd
    • 11.6.1 F. Hoffmann-La Roche Ltd Company Details
    • 11.6.2 F. Hoffmann-La Roche Ltd Business Overview
    • 11.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Introduction
    • 11.6.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.6.5 F. Hoffmann-La Roche Ltd Recent Development
  • 11.7 Intertek Group plc
    • 11.7.1 Intertek Group plc Company Details
    • 11.7.2 Intertek Group plc Business Overview
    • 11.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Introduction
    • 11.7.4 Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.7.5 Intertek Group plc Recent Development
  • 11.8 Lonza Group AG
    • 11.8.1 Lonza Group AG Company Details
    • 11.8.2 Lonza Group AG Business Overview
    • 11.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Introduction
    • 11.8.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.8.5 Lonza Group AG Recent Development
  • 11.9 Merck KGaA
    • 11.9.1 Merck KGaA Company Details
    • 11.9.2 Merck KGaA Business Overview
    • 11.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Introduction
    • 11.9.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.9.5 Merck KGaA Recent Development
  • 11.10 Sartorius AG
    • 11.10.1 Sartorius AG Company Details
    • 11.10.2 Sartorius AG Business Overview
    • 11.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Introduction
    • 11.10.4 Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.10.5 Sartorius AG Recent Development
  • 11.11 SGS S.A.
    • 11.11.1 SGS S.A. Company Details
    • 11.11.2 SGS S.A. Business Overview
    • 11.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Introduction
    • 11.11.4 SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.11.5 SGS S.A. Recent Development
  • 11.12 Sistemic Scotland Limited
    • 11.12.1 Sistemic Scotland Limited Company Details
    • 11.12.2 Sistemic Scotland Limited Business Overview
    • 11.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Introduction
    • 11.12.4 Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.12.5 Sistemic Scotland Limited Recent Development
  • 11.13 Thermo Fisher Scientific Inc.
    • 11.13.1 Thermo Fisher Scientific Inc. Company Details
    • 11.13.2 Thermo Fisher Scientific Inc. Business Overview
    • 11.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Introduction
    • 11.13.4 Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.13.5 Thermo Fisher Scientific Inc. Recent Development
  • 11.14 Vigene Biosciences, Inc.
    • 11.14.1 Vigene Biosciences, Inc. Company Details
    • 11.14.2 Vigene Biosciences, Inc. Business Overview
    • 11.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Introduction
    • 11.14.4 Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.14.5 Vigene Biosciences, Inc. Recent Development
  • 11.15 WuXi AppTec
    • 11.15.1 WuXi AppTec Company Details
    • 11.15.2 WuXi AppTec Business Overview
    • 11.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Introduction
    • 11.15.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
    • 11.15.5 WuXi AppTec Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Cell and Gene Therapy Manufacturing QC Scope and Market Size
    Cell and Gene Therapy Manufacturing QC market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell and Gene Therapy Manufacturing QC market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Safety Testing
    Purity Testing
    Potency Testing
    Identity Testing
    Stability Testing

    Segment by Application
    Precision Therapy
    Biological Research

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Bio-Techne Corporation
    BioMerieux SA
    Catalent, Inc.
    Charles River Laboratories International Inc.
    Eurofins Scientific SE
    F. Hoffmann-La Roche Ltd
    Intertek Group plc
    Lonza Group AG
    Merck KGaA
    Sartorius AG
    SGS S.A.
    Sistemic Scotland Limited
    Thermo Fisher Scientific Inc.
    Vigene Biosciences, Inc.
    WuXi AppTec


    Summary:
    Get latest Market Research Reports on Cell and Gene Therapy Manufacturing QC. Industry analysis & Market Report on Cell and Gene Therapy Manufacturing QC is a syndicated market report, published as Global Cell and Gene Therapy Manufacturing QC Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Cell and Gene Therapy Manufacturing QC market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,761.20
    4,141.80
    5,522.40
    3,205.80
    4,808.70
    6,411.60
    426,192.00
    639,288.00
    852,384.00
    285,948.00
    428,922.00
    571,896.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report